|
COMMERCE BUSINESS DAILY ISSUE OF APRIL 22,1997 PSA#1829U.S. Nuclear Regulatory Commission, Division of Contracts, Mail Stop
T-7-I-2, Washington, D.C. 20555 B -- DETERMINISTIC EFFECTS OF OCCUPATIONAL EXPOSURE TO RADIATION SOL
RS-RES-97-051 POC Mary H. Mace, Contracting Officer, 301/415-7314/,
Stephen Pool, Contract Specialist, 301/415-8168 The Nuclear Regulatory
Commission (NRC), intends to negotiate a sole source contract with the
University of Pittsburgh to initiate and implement, in conjunction with
Branch Nuclear Number 1 -- Institute of Biophysics (FIB-1), Ozyorsk,
Russian Federation (RF), recommendations resulting from a feasibility
study. This feasibility study was co-developed and co-funded by the NRC
and DOE in conjunction with the Russian Federation under the auspices
of the Joint Coordination Committee on Radiation Effects Research
(JCCRER). The objective of this feasibility study was to test the
feasibility of developing a computerized database containing all of the
clinical and dosimetric information collected over 45 years on the
Mayak Production Association (PA), Ozyorsk, RF, worker population and
analyzing it for dose-response relationships of deterministic health
effects and the validation of predictive models for the consequences of
significant radiation exposure. This study shows that a computerized
database containing clinical and dosimetric information could be
established and subsequently analyzed in order to establish dose-
response relationships and validate predictive models of the
consequences of significant radiation exposures. It also recommended
that: (1) a comprehensive analysis of the feasibility study database be
initiated; (2) the database be expanded to include all of the acute
radiation syndrome, plutonium pneumonitis and chronic radiation
sickness cases, as well as a group of randomly selected case-control
records; (3) clinical and dosimetric analyses of the entire acute
radiation syndrome and plutonium pneumonitis subsets be initiated; and
(4) risk assessment models described in NUREG/CR-4214 for predicting
deterministic health effects be tested. NRC knows of no other research
team with the requisite qualifications and experience to conduct this
work in conjunction with the FIB-1 and Mayak PA research team other
than the University of Pittsburgh. This research team has been involved
with assessing the adverse health effects of internal and external
radiation exposure at U.S. and former Soviet nuclear facilities since
the 1980's. All of the members on this research team have considerable
experience working with FIB-1 physicians and scientists and Mayak PA
scientists with this and other studies involving the Mayak PA nuclear
workers. Equally important, the University of Pittsburgh, the FIB-1,
and Mayak PA research teams have developed a delicate and collegial
relationship. This relationship has been nurtured for two years. No
other research team: (1) has the medical and dosimetry expertise
needed, (2) has thorough familiarity with NRC health effects models,
(3) has access to the FIB-1 and Mayak PA medical and dosimetry archive,
and (4) has already established a working relationship with the FIB-1
and Mayak PA research team. The period of performance for this effort
is 3 years. This is a notice of intent to contract only. A solicitation
document does not exist. Interested parties should submit written
technical documentation to the NRC describing their applicable medical
and dosimetry expertise; familiarity with NRC health effects models;
ability to obtain access to the FIB-1 and Mayak PA medical and
dosimetry archive; and current working relationship with the FIB-1 and
Mayak PA research team to satisfy NRC's needs to: U.S. Nuclear
Regulatory Commission, Division of Contracts, Attn: Stephen Pool, Mail
Stop T-7-I-2, Washington, DC 20555. Telephonic and/or telegraphic
responses and responses providing insufficient information for
evaluation will not be considered. See Note 22. (0108) Loren Data Corp. http://www.ld.com (SYN# 0017 19970422\B-0004.SOL)
B - Special Studies and Analyses - Not R&D Index Page
|
|